Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel ®
Conclusion
Acthar may be a useful treatment option compared to PMP/IVIG for patients with MS experiencing multiple relapses.
Funding
This study was funded by a grant to the University of Washington from Mallinckrodt Pharmaceuticals.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Grants | Healthcare Costs | Hospital Management | Methylprednisolone | Multiple Sclerosis | Study | University of Washington